Special Events : Agenda

Special Events

Agenda

Conference Agenda

MANAGING METASTATIC BREAST CANCER:
PRESENT AND NEW TREATMENT OPTIONS

2nd Annual Metastatic Breast Cancer Network Conference
November 17, 2007, 9:30 - 5:30 p.m. / November 18, 2007, 9:30 - 3:00 p.m.
UT M. D. Anderson Cancer Center
Hickey Auditorium / R11.1400

Saturday, November 17, 2020
09:30 – 9:40 a.m.	Welcome Presentation, MBCN Representative
9:40 - 9:45 a.m.	Welcome to MDACC by W. Fraser Symmans, Professor, Pathology
09:45 - 10:15 a.m.	"Molecular Classifications of Breast Cancer and its Applications to Prognosis and Selection of Treatment." W. Fraser Symmans, MD, Professor, Pathology, UT M. D. Anderson Cancer Center
10:15 – 10:30 a.m.	Question & Answer Session
10:30 – 11:00 a.m.	“Targeted Therapy for Metastatic Breast Cancer” PK Morrow, MD, Assistant Professor, Breast Medical Oncology, UT M. D. Anderson Cancer Center
11:00 – 11:15 a.m.	Question & Answer Session
11:15-11:45 a.m.	“What IS New In Therapeutics Vaccines in Breast Cancer” Nuhad K. Ibrahim, MD, BS, Associate Professor, Breast Medical Oncology, UT M. D. Anderson Cancer Center (This presentation may be presented by James Lee Murray, MD, BA, Professor, Breast Medical Oncology)
11:45 – 12:00 p.m.	Question & Answer Session
12:00 - 1:00 p.m.	Lunch
Saturday, November 17, 2020 Continued
1:00 – 1:30 p.m.	“Current Use of Chemotherapy in the Management of MetastaticBreast Cancer and New Chemotherapy Agents” Vicente Valero, MD, Professor, Breast Medical Oncology, UT M. D. Anderson Cancer Center
1:30 - 1:40 p.m.	Question & Answer Session
1:40 – 2:10 p.m.	“New Directions in Radiotherapy for Metastatic Breast Cancer” Welela Tereffe, MD, Assistant Professor, Radiation Oncology, UT M. D. Anderson Cancer Center
2:10 – 2:25 p.m.	Question & Answer Session
2:30 – 3:00 p.m.	"Circulating Tumor Cell (CTCs) and prognostic stratification in Metastatic Breast Cancer (MBC): Toward Personalized Therapy" Massimo Cristofanilli, MD, Associate Professor, Breast Medical Oncology, UT M. D. Anderson Cancer.
3:00 – 3:15 p.m.	Question & Answer Session
3:15 – 3:30 p.m.	Allow people to break up and attend the talk they prefer. Introduce the breakout sessions as well to follow the concurrent talks.
3:30 – 4:15 p.m.	3 concurrent talks with the doctors: Each presentation will end with Q/A for 15 minutes. "Triple Negative." Dr. Marjorie Green, UT M.D. Anderson Cancer Center "Advance in Treatment of Bone Metastasis" Naoto Ueno, MD, PhD, Associate Professor, Breast Medical Oncology UT M. D. Anderson Cancer Center "Surgical Management of Metastatic Breast Cancer" Gildy Babiera, MD, Associate Professor, Surgical Oncology, UT M. D. Anderson Cancer Center
4:30 – 5:30	Breakout sessions a.Sexuality (Dr. Schover, PhD, Professor, Behavioral Science) b. Learning to live with Uncertainty - a Patient with more than 8 years c. Issues of Insurance: (Dr. Walters, MD, BS, MS, MBA, Associate Vice President of Medical Operations and Informatics) d. How to talk to Children: (Martha Aschenbrenner, Pediatrics Program Manager) e. How to talk to a metastatic patient (for family and friends)
6:00 – 8:00 p.m.	Reception
Sunday, November 18, 2020
09:30 – 9:40 a.m.	Welcome and Introduction for the day. MBCN Representative
9:40 – 10:10 a.m.	“Breast Cancer Stem Cells” Wendy Woodward, MD, PhD, Assistant Professor, Radiation Oncology, UT M. D. Anderson Cancer Center
10:10 – 10:25 a.m.	Question and Answer Session
10:30 – 11:00 a.m.	“Future Directions in Treatment of Metastatic Breast Cancer” Vicente Valero, MD, Professor, Breast Medical Oncology, UT M. D. Anderson Cancer Center
11:00 - 11:15 a.m.	Question and Answer Session
11:15– 1:00 p.m.	Lunch Break
1:00 - 2:00 p.m.	Panel Discussion Aman Buzdar, MD, Co-Chair & Professor, Breast Medical Oncology, UT M. D. Anderson Cancer Center
2:00 – 3:00 p.m.	Panel Discussion with Pharmaceutical Representatives: Aman Buzdar, MD, Co-Chair & Professor, Breast Medical Oncology, UT M. D. Anderson Cancer Center; Angela Ogden, MD, Vice President of Global Medical Affairs, Abraxis; Collier Smyth, MD, Senior Vice President of Medical Strategy, Oncology, Bristol Meyers Squibb; Nina Schulman, Co-founder of MBCN; Banu Ozden, Ph.D, Founder, CEO of SmartMedicalConsumer.